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Abstract
Background
Little is known about heart diseases and their treatment in rural sub-Saharan Africa. This
study aimed to describe the occurrence, characteristics, and etiologies of heart diseases,
and the medication taken before and prescribed after echocardiography in a rural referral
Hospital in Tanzania.
Methods
This prospective descriptive cohort study included all adults and children referred for echo-
cardiography. Clinical and echocardiographic data were collated for analysis.
Results
From December 2015 to October 2017, a total of 1’243 echocardiograms were performed.
A total of 815 adults and 59 children�15 years had abnormal echocardiographic findings; in
adults 537/815 (66%) had hypertension, with 230/537(43%) on antihypertensive drugs, and
506/815 (62%) were not on regular cardiac medication; 346/815 (42%) had severe eccentric
or concentric left ventricular hypertrophy, and 182/815 (22%) had severe systolic heart fail-
ure. Only 44% demonstrated normal left ventricular systolic function. The most frequent
heart diseases were hypertensive heart disease (41%), valvular heart disease (18%), coro-
nary heart disease (18%), peripartum cardiomyopathy (7%), and other non-hypertensive
dilated cardiomyopathies (6%) in adults, and congenital heart disease (34%) in children. Fol-
lowing echocardiography, 802/815 (98%) adults and 40/59 (68%) children had an indication
for cardiac medication, 70/815 (9%) and 2/59 (3%) for oral anticoagulation, and 35/815 (4%)
and 23/59 (39%) for cardiac surgery, respectively.
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Conclusion
Hypertension is the leading etiology of heart diseases in rural Tanzania. Most patients pres-
ent with advanced stages of heart disease, and the majority are not treated before echocar-
diography. There is an urgent need for increased awareness, expertise and infrastructure to
detect and treat hypertension and heart failure in rural Africa.
Introduction
Non-communicable diseases are underappreciated in countries with a low-middle socio-
demographic index (SDI), even though disability adjusted life-years (DALYs, the sum of the
years of life lost due to premature mortality and years of life lived with disability) due to non-
communicable diseases increased by 54% during the last 25 years [1].
Although DALYs from communicable, maternal, and nutritional diseases still account for
more than those from non-communicable diseases in sub-Saharan Africa, cardiovascular dis-
eases are increasingly present among the leading causes of total DALYs in countries with a low
SDI [1]. According to World Health Organisation (WHO) estimates, cardiovascular diseases
are the second most common cause of death in Africa. In 2015, almost 1.2 million people died
because of cardiovascular diseases in Africa, which is more than for malaria and tuberculosis
combined [2]. Mortality of patients with heart failure has been reported to be highest in Africa,
compared to other low- and middle income regions: The INTER CF prospective cohort study
including patients from Asia, South America, Africa, and the Middle East showed a one year
overall mortality of 16.5%, but for Africa alone the mortality was estimated at 34% [3]. The
most commonly reported etiology of heart failure in low- and middle-income regions is ische-
mic heart disease, except for the Americas and Africa, where hypertension is the predominant
cause [4]. A recent systematic review and meta-analysis of 22 studies from Africa (1999–2017)
including 10’098 patients found hypertensive heart disease (39.2%) to be the commonest cause
of heart failure, followed by cardiomyopathies (21.4%), and rheumatic heart disease (14.1%).
Ischemic heart disease was reported to be rare (7.2%) [5]. However, most patients included
were from urban hospitals, and only a minority (603/10’098, 6%) originated from rural areas,
where cardiomyopathies and rheumatic heart disease appeared to be most common causes for
heart failure in small studies from rural Rwanda and rural Cameroon [6, 7]. In the same review
[5], 9 included studies analyzed the use of cardiac medication given at admission or at dis-
charge from a hospital. However, only 11% of the patients represented rural areas from sub-
Saharan Africa, and the proportion of patients on cardiac medication at presentation to a clinic
was not described yet. In this study, we describe the occurrence, characteristics, and etiologies
of heart diseases diagnosed using echocardiography in patients from the rural Kilombero- and
Ulanga districts in Tanzania, and describe the medication taken before and prescribed after
echocardiography.
Material and methods
Ethics statement
The study was approved by ethics committee in Switzerland (Ethikkommission Nordwest und
Zentralschweiz (EKNZ UBE-15/83)) and the ethics committees of the Ifakara Health Institute
(Institutional Review Board, IHI/IRB/No 38–2015) as well as the National Institute for Medical
Research, Tanzania (Ref. NIMR/HQ/R.8a/Vol. IX/2242). All three committees waived
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informed consent, to minimize selection bias, and due to the substantial benefit for the study
population.
Study site
The St Francis Referral Hospital is situated in Ifakara in Tanzania and serves as a referral cen-
ter for a rural population of about one million inhabitants form the Kilombero- and Ulanga
districts. It has 360 beds and specialized services in internal medicine, surgery, obstetrics, neo-
natology and gynecology, ophthalmology, pediatrics, and has an HIV and tuberculosis clinic.
In September 2015, an emergency department including a triaging system and training of
medical staff in emergency medicine, sonography and echocardiography was implemented.
Since January 2016, this emergency department has been open 24 hours a day, caring for over
36’000 patients per year, and is the only site in the Kilombero- and Ulanga region where echo-
cardiography is available.
Study design
All symptomatic patients (i.e adults including pregnant women, and children�15 years with
dyspnea, orthopnoea or chest pain of all ages) who were referred to the emergency department
for echocardiography were eligible for this prospective descriptive cohort study. Over 22 con-
secutive months the medical histories, clinical examination results and echocardiographic data
were collected for these patients and collated for analysis.
Data collection
Clinical data (medical history including symptoms and medication, physical examination includ-
ing weight, height, body surface area, blood pressure (BP) and heart rate) were consecutively col-
lected on a dedicated case report form (EpiData). BP was measured with a manual BP meter in
sitting position, after a minimum of 5 minutes of rest. Prior to echocardiography, history taking
and physical examination including inspection, palpation of the apex beat, and auscultation of the
heart and lungs was performed in all patients by the echocardiographer. Initial electrocardiograms
(ECG) and chest x-rays were done according to the decision of the referring clinician.
Echocardiography
Two-dimensional echocardiography with color-, pulse wave (PW)-, continuous wave (CW)-
and tissue doppler imaging (TDI) was performed with a Mindray M7 ultrasound machine
(Mindray, Shenzhen, China) using a P4-2s phased array transducer. Detailed echocardio-
graphic assessment of ventricular and atrial size, left- and right ventricular systolic and dia-
stolic function, regional wall abnormalities, and valvular structures and function was
conducted and interpreted according to recent recommendations and international guidelines
[8–15]. End-systolic and end-diastolic left ventricular (LV) volumes and LV ejection fraction
(EF) were calculated by the Simpson method of discs. To measure and interpret LV diastolic
function and to estimate LV end-diastolic- and left atrial filling pressure (LAP), mitral inflow-
(E/A), mitral septal annulus- (e’), and tricuspid regurgitation (TR) velocity, E/e’, left atrium
(LA) volume index, and pulmonary venous flow was used. In case of valvular heart disease
with mitral valve stenosis or at least moderate mitral valve regurgitation, diastolic function and
LAP was considered to be determinable only if Ar-A�30msec, and in case of depressed EF
only, if septal E/e’ >15 [9]. To measure the right ventricular function, tricuspid annular plane
systolic excursion (TAPSE), right ventricular systolic excursion velocity by TDI (s’), fractional
area change (FAC), and myocardial performance index (MPI) was used. To estimate
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pulmonary artery pressure, TR velocity, MPI, pulmonary valve acceleration time/right ventric-
ular ejection time (PVAccT/RVET), and deceleration index (DI) was used. The right atrial
pressure was estimated by inferior vena cava (IVC) diameter and the presence of its inspiratory
collapse. To evaluate the severity of valvular regurgitation, an integrative approach was used,
including the proximal isovelocity surface area (PISA) method if appropriate [10]. To quantify
mitral stenosis, planimetry of the valve area and mean gradient was used. All echocardio-
graphic procedures were done by the last author, who prescribed all medication, and recom-
mended heart surgery and anticoagulation according to current guidelines [16–20].
Definitions
Hypertension. Systolic BP>140mmHg or diastolic BP>90mmHg, measured after a min-
imum of 5 minutes of rest in sitting position, and at least one documented BP of>140/
90mmHg at another occasion, or presence of an established antihypertensive therapy and a
documented BP of>140/90mmHg in the past [21, 22].
Hypertensive heart disease. Hypertrophy or concentric remodeling of the left ventricle
with or without global systolic or diastolic left ventricular dysfunction in a patient with arterial
hypertension, with neither valve disease nor segmental wall motion abnormalities.
Dilated cardiopathy. Eccentric hypertrophy of the left ventricle and dilated atria or
dilated right ventricle.
Valvular heart disease. Abnormal size and/or function of the heart and a primary abnor-
mality of a valve (i.e. presence of valve regurgitation or stenosis and thickening of cusps, leaf-
lets, or leaflet tips, vegetations or ruptured chordae tendineae).
Rheumatic heart disease. Definition according to the 2012 world heart federation
(WHF) criteria for echocardiographic diagnosis of rheumatic heart disease [23].
Endocarditis. Definition according the Duke criteria for diagnosis of infective endocardi-
tis [24].
Coronary heart disease. Typical angina pectoris and ventricular dysfunction with seg-
mental hypo- or akinesia which could be attributed to a specific coronary artery with or with-
out typical ECG-findings.
Peripartum cardiomyopathy. Cardiomyopathy with a reduced left ventricular ejection
fraction of<45%, presenting towards the end of the pregnancy or in the months after delivery
in a woman without previously known structural heart disease [25].
Hypertrophic cardiomyopathy. A heart with a LV with concentric hypertrophy.
Right heart failure. Right ventricular dysfunction with a fractional area change (FAC)
<32%.
Pulmonary heart disease. Right heart failure in presence of pulmonary hypertension and
normal LAP.
TB-pericarditis. Pericardial effusion in a patient with clinically suspected or microbiolog-
ically confirmed tuberculosis (TB).
Constrictive pericarditis. Echocardiographical signs of constriction in a patient with sus-
pected or confirmed TB.
Endomyocardial fibrosis and congenital heart diseases. Definition according to current
recommendations [19, 26].
Hypertrophy of the left ventricle in children. LV mass (LVM)/height2.7 above the 95th
percentile [13]; severe LV hypertrophy: LVM of at least 30% above the 95th percentile.
Concentric hypertrophy. Increased LVM and a relative wall thickness (RWT)�0.42;
eccentric hypertrophy, increased LVM and RWT<0.42; concentric remodelling, normal
LVM with a RWT�0.42 [8].
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Statistical analysis
In this study only descriptive statistical analysis was applied, using Microsoft Excel, after
export of the data from EpiData.
Results
From December 2015 through to October 2017, a total of 1’243 echocardiograms were per-
formed. After exclusion of 278 (22%) echocardiograms of patients with completely normal
findings and 64 (5%) echocardiograms with non-relevant findings only (i.e minimal or mild
mitral valve regurgitation in presence of normal leaflet morphology, and no other evidence of
heart disease), 901 echocardiograms of symptomatic patients with a heart disease were
included. After exclusion of 27 follow-up examinations, 874 echocardiograms of 874 patients
were analyzed.
Patient characteristics
Table 1 outlines the patient’s characteristics: A total of 815 were adults, and 59 were children
�15 years. A total of 199/874 (23%) were admitted to the hospital ward. Median age of the
adults was 59 years (range 16–98), 329/815 (40%) were male, 282/815 (35%) had overweight or
were obese, and 537/815 (66%) had hypertension. A total of 41/815 (5%) adults were HIV posi-
tive. At presentation, 506/815 (62%) were not on regular medication. Among those who had
hypertension, only 230/537 (43%) took at least one antihypertensive drug, while BP was>140/
90mmHg in 358/537 (67%), and BP was�160/100mmHg in 287/537 (53%). A total of 68/815
(8.3%) had atrial fibrillation.
The median age of children presenting was 5 years (range 0.003–15), of which 27/59 (46%)
were male, and 17/59 (33%) had underweight.
Echocardiographic findings
Table 2 outlines interpretations of echocardiographic findings, which are shown in detail in S1
Table. Only 93/815 (11%) adults had a normal sized left ventricle, and 353/815 (44%) had a
normal left ventricular systolic function. On the other hand, 346/815 (42%) had severe eccen-
tric or concentric hypertrophy of the left ventricle, and 182/815 (22%) had severe systolic heart
failure.
Etiology of heart diseases
Hypertension was the main cause or a concomitant cause for heart disease in 510/815 (63%)
adults. Table 3 and Fig 1 gives an overview of the distribution of different heart diseases in
adults and children. In adults, the most frequent heart diseases were hypertensive heart disease
(337/815, 41%), valvular heart disease (146/815, 18%), coronary heart disease (145/815, 18%),
peripartum cardiomyopathy (56/815, 7%), other non-hypertensive dilated cardiomyopathies
(52/815, 6%), and pulmonary heart disease (37/815, 5%).
S2 Table outlines detailed echocardiographic findings of adult patients with rheumatic
heart disease. Of the 146 adults with valvular heart disease, 68/146 (47%) fulfilled the criteria
for rheumatic heart disease according to WHF criteria [23]. Most common was moderate or
severe mitral regurgitation, which was present in 40/68 (59%) patients. Out of 16 patients with
mitral stenosis, 13 (81%) were moderate or severe.
A total of 48/68 (71%) patients had an impaired left ventricular systolic function, and 32/68
(47%) had an impaired right ventricular function.
Heart diseases in rural Tanzania
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S2 Table outlines detailed echocardiographic findings of patients with peripartum cardio-
myopathy. Of 56 patients with peripartum cardiomyopathy, 48/56 (86%) had moderate or
severe systolic heart failure, and 21/56 (38%) had severe eccentric hypertrophy.
Heart failure with preserved ejection fraction (HFpEF): Of all patients, only 32/815 (4%)
had HFpEF (i.e. EF� 50% and elevated LV-filling pressure).
The most frequent heart diseases in children were congenital heart disease (20/59, 34%),
valvular heart disease (12/59, 20%), with 5/12 (42%) fulfilling the criteria for rheumatic heart
disease, dilated cardiomyopathy (9/59, 15%), and right heart failure due to pulmonal hyperten-
sion (7/59, 12%).
Table 1. Baseline characteristics.
Patient characteristics Adults (n = 815) Children (n = 59)
Age [years], median (range) 59 (16–98) 5 (0.003–15)
Children<5 years, n (%) N/A 28 (47%)
Male sex, n (%) 329 (40%) 27 (46%)
Weight [kg] (n = 793)/(n = 55), median (range) 60 (30–150) 16 (2–43)
Height [cm] (n = 793)/(n = 51), median (range) 160 (103–190) 106 (50–162)
BSA [m2] (n = 793)/(n = 51), median (range) 1.62 (1.1–2.66) 0.7 (0.22–1.41)
BMI [kg/m2] (n = 793)/(n = 51), median (range) 23.19 (13.16–57.85) N/A
Underweight (n = 793)/(n = 51), n (%) 86 (11%) 17 (33%)
Normal weight (n = 793)/(n = 51), n (%) 425 (54%) 28 (55%)
Overweight (n = 793)/(n = 51), n (%) 165 (21%) 5 (10%)
Obesity (n = 793)/(n = 51), n (%) 117 (15%) 1 (2%)
Hypertension, n (%) 537 (66%) 2 (3%)
Stroke, n (%) 53 (7%) 0 (0%)
Pregnancy in the last 6 months, n (%) 68 (8%) 0 (0%)
No medication before presentation, n (%) 506 (62%) 44 (75%)
Inpatient, n (%) 178 (22%) 21 (36%)
HIV positive, n (%) 41 (5%) 0 (0%)
Symptoms and clinical findings
Dyspnoea, n (%) 485 (60%) 32 (54%)
Orthopnoea, n (%) 398 (49%) 19 (32%)
Chest pain, n (%) 230 (28%) 8 (14%)
Systolic BP [mmHg] (n = 806)/(n = 23), median (range) 140 (70–260) 115 (80–165)
Diastolic BP [mmHg] (n = 806)/(n = 23), median (range) 80 (30–150) 70 (40–120)
HR [beat/min] (n = 764)/(n = 44), median (range) 80 (36–160) 110 (70–200)
Irregular heartbeat, n (%) 118 (14%) 3 (5%)
Dilated jugular veins, n (%) 217 (27%) 2 (3%)
Apical beat lateralised, n (%) 257 (32%) 15 (25%)
Heart murmur, n (%) 158 (19%) 31 (53%)
N/A, not applicable; BSA, body surface area; BMI, body mass index; HR, heart rate; BP, blood pressure.
The numbers (n = )/(n = ) after each patient characteristic indicate for how many adults and children data were available.
Underweight: BMI<18.5 kg/m2 for adults, or BMI for age 2 or 3 standard deviations (SD) below the WHO growth
reference for children�5 years old, or weight for height 2 or 3 SD below the WHO growth reference for children<5
years old; Normal weight: BMI 18.5 to<25 kg/m2 for adults, or children who have no overweight nor obesity nor
underweight; Overweight: BMI 25 to<30 kg/m2 for adults, or BMI for age 1 SD above the WHO growth reference for
children�5 years old, or weight for height 2 SD above the WHO growth reference for children<5 years old; Obesity:
BMI�30 kg/m2 for adults, or BMI for age�2 SD above the WHO growth reference for children�5 years old, or weight
for height 3 SD above the WHO growth reference for children<5 years old.
https://doi.org/10.1371/journal.pone.0208931.t001
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Indications for medication and cardiac surgery
After echocardiography, 802/815 (98%) adults and 40/59 (68%) children had an indication for
cardiac medication, 70/815 (9%) adults and 2/59 (3%) children for oral anticoagulation, and
35/815 (4%) adults and 23/59 (39%) children for cardiac surgery. In 700/815 (86%) adults and
32/59 (54%) children at least one new drug was added, in 199/815 (24%) adults and 6/59 (10%)
Table 2. Interpretation of echocardiographic findings.
Adults (n = 815) Children (n = 59)
Normal LV size, n (%) 93 (11%) 29 (49%)
Concentric remodelling, n (%) 161 (20%) 10 (17%)
Concentric hypertrophy, n (%) 299 (37%) 6 (10%)
- Concentric hypertrophy, severe, n (%) 191 (23%) 5 (8%)
Eccentric hypertrophy, n (%) 262 (32%) 14 (24%)
- Eccentric hypertrophy, severe, n (%) 155 (19%) 10 (17%)
Normal systolic LV function (LVEF�54%) (n = 811)/(n = 58), n (%) 353 (44%) 44 (76%)
Mild systolic heart failure (LVEF 41–53%) (n = 811)/(n = 58), n (%) 101 (12%) 3 (5%)
Moderate systolic heart failure (LVEF 30–40%) (n = 811)/(n = 58), n (%) 175 (22%) 5 (9%)
Severe systolic heart failure (LVEF <30%) (n = 811)/(n = 58), n (%) 182 (22%) 6 (10%)
Diastolic relaxation impairment of left ventricle
- None, n (%) 260 (32%) 25 (42%)
- Grade 1, n (%) 125 (15%) 2 (3%)
- Grade 2, n (%) 112 (14%) 5 (8%)
- Grade 3, n (%) 179 (22%) 7 (11%)
- Diastolic function not determinable, n (%) 139 (17%) 20 (33%)
Diastolic relaxation impairment grade 2 or 3 and LVEF�50%, n (%) 32 (4%) 1 (2%)
Right ventricle, size
- Normal size, n (%) 444 (54%) 29 (49%)
- Dilated or hypertrophic, n (%) 371 (46%) 30 (51%)
Right ventricle, function
- normal, n (%) 542 (67%) 42 (71%)
- impaired, n (%) 273 (33%) 17 (29%)
Pulmonary hypertension
- no (n = 797)/(n = 58), n (%) 464 (58%) 34 (59%)
- due to left sided heart disease (i.e. elevated LAP) (n = 797)/(n = 58), n
(%)
292 (37%) 17 (29%)
- due to other cause (n = 797)/(n = 58), n (%) 41 (5%) 7 (12%)
Aortic regurgitation, moderate or severe, n (%) 58 (7%) 1 (2%)
Aortic stenosis, moderate or severe, n (%) 3 (0%) 0 (0%)
Mitral regurgitation, moderate or severe, n (%) 157 (19%) 11 (19%)
Mitral stenosis, any, n (%) 16 (2%) 2 (3%)
Mitral stenosis, moderate or severe, n (%) 13 (2%) 2 (3%)
Mitral stenosis, severe, n (%) 8 (1%) 1 (2%)
Pulmonal regurgitation, moderate or severe, n (%) 11 (1%) 1 (2%)
Pulmonal stenosis, moderate or severe, n (%) 0 (0%) 6 (10%)
Tricuspid regurgitation, moderate or severe, n (%) 101 (12%) 11 (19%)
LV, left ventricle; LVEF, left ventricular ejection fraction; LAP, left atrial pressure. The numbers (n = )/(n = ) indicate
for how many adults and children data were available.
https://doi.org/10.1371/journal.pone.0208931.t002
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children the dose of at least one drug was increased, and in 191/815 (23%) adults and 9/59
(15%) children, at least one drug was stopped.
Fig 2 shows the drugs taken before and prescribed after echocardiography. Most prescribed
drugs after echocardiography were ACE-inhibitors, diuretics, and beta-blockers.
Discussion
Of 1’243 echocardiograms performed within 22 consecutive months, 901 (72%) had relevant
pathologies. Most patients presented with advanced stages of heart failure. The majority of
patients with heart disease had not been treated before echocardiography, although almost all
had an indication for treatment. The most frequent heart disease was hypertensive heart dis-
ease, followed by valvular-, and coronary heart disease, and cardiomyopathies. More than
one third of children had an indication for cardiac surgery, and 9% of the adults for oral antic-
oagulation. High blood pressure was not well controlled in two thirds of the patients with
hypertension. To date, this is the largest prospective cohort study reporting on occurrence,
characteristics, and etiologies of heart diseases conducted at a rural site in Africa—our results
Table 3. Causes of heart disease in 874 patients.
Adults (n = 815) Children (n = 59)
Hypertensive HD, n (%) 337 (41%) 3 (5%)
- Hypertensive dilated cardiopathy with eccentric hypertrophy, n (%) 76 (9%) 1 (2%)
- Hypertensive HD with concentric hypertrophy, n (%) 160 (20%) 2 (3%)
Valvular HD, n (%) 146 (18%) 12 (20%)
- Rheumatic HD, n (%) 68 (8%) 5 (8%)
- Endocarditis, n (%) 9 (1%) 2 (3%)
- Valvular HD with hypertension, n (%) 43 (5%) 0 (0%)
Coronary HD, n (%) 145 (18%) 0 (0%)
- Coronary HD without hypertension, n (%) 29 (4%) 0 (0%)
- Coronary HD with hypertension, n (%) 116 (14%) 0 (0%)
Peripartum cardiomyopathy, n (%) 56 (7%) 0 (0%)
- Peripartum cardiomyopathy with hypertension, n (%) 14 (2%) 0 (0%)
Dilated cardiomyopathy, other, n (%) 52 (6%) 9 (15%)
Hypertrophic cardiomyopathy, other, n (%) 8 (1%) 2 (3%)
Endomyocardial fibrosis, n (%) 3 (0.4%) 1 (2%)
TB-pericarditis, n (%) 16 (2%) 5 (8%)
Pericarditis constrictiva, n (%) 8 (1%) 0 (0%)
Right heart failure due to pulmonal hypertension/normal LAP, n (%) 37 (5%) 7 (12%)
Arrhythmogenic right ventricular cardiomyopathy, n (%) 2 (0.2%) 1 (2%)
VSD�, n (%) 2 (0.2%) 6 (10%)
ASD, n (%) 3 (0.4%) 6 (10%)
TOF, n (%) 0 (0%) 6 (10%)
Complete AV defect, n (%) 0 (0%) 1 (2%)
PDA, n (%) 0 (0%) 6 (10%)
HD, heart disease; TB, tuberculosis; LAP, left atrial pressure; VSD, ventricular septal defect; ASD, atrial septal defect;
TOF, Tetralogy of Fallot; AV, atrioventricular; PDA, patent ductus arteriosus. � VSD in absence of TOF. Children
with congenital heart disease: n = 20 (34%). Two children with TOF had concomitant ASD and one child with TOF
had concomitant PDA. One child had VSD and ASD, one child had VSD, ASD and PDA.
https://doi.org/10.1371/journal.pone.0208931.t003
Heart diseases in rural Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0208931 December 26, 2018 8 / 16
reflect the extent and burden of heart diseases, and the neglect of their awareness and manage-
ment in sub-Saharan Africa.
The high frequency of hypertensive heart disease is in line with the recent meta-analysis of
22 African studies in mostly urban patients [5], and stands in contrast to two studies from
rural Rwanda and Cameroon, where cardiomyopathies and rheumatic heart disease were
more common [6, 7]. We observed more coronary heart disease, less rheumatic heart disease,
and less cardiomyopathies than previously reported [5]. However, it is likely that the preva-
lence of coronary heart disease was underestimated in previous studies, due to inadequate
diagnostic methods, a paucity of physicians, and unreliable health statistics [27]. The high
occurrence of poorly controlled hypertension, and the high proportion of untreated patients at
presentation in our study is in line with a recent large cross-sectional study, which showed a
high cumulative prevalence of cardiovascular risk factors in urban and rural Malawi. The
crude prevalence of hypertension was 14.7% in the urban area and 13.6% in the rural area, and
many people with hypertension (900/2208 (41%) urban and 1188 /1888 (63%) rural) were not
overweight or obese. Only 29% were taking regular antihypertensive medication, and less than
half of those had a well-controlled BP (i.e. below 140/90mmHg) [28]. A meta-analysis of stud-
ies from 2000 to 2013 in sub-Saharan Africa showed that the prevalence of hypertension at
ages of 30, 40, 50 and 60 years was 16%, 26%, 35%, and 44%, respectively. Only 7%-56% were
aware of their hypertensive status, 18% were receiving antihypertensive drugs, but only 7%
Fig 1. Distribution of heart diseases in adults (A) and in children (B). HD, heart disease; TB, tuberculosis.
https://doi.org/10.1371/journal.pone.0208931.g001
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had adequately controlled blood pressure [29]. In another observational cross-sectional study
in mostly urban areas of 12 sub-Saharan African countries, 77% had uncontrolled hyperten-
sion, although 97% were under antihypertensive medication. The proportion of uncontrolled
hypertension increased with decreasing level of patient wealth, and higher grade of hyperten-
sion was seen in the lower wealth categories [30]. Among other risk factors such as overweight
and reduced physical activity, a reduced urine sodium concentrating ability, increased sodium
sensitivity, low plasma renin values, mutations of epithelial sodium channels and other genetic
factors might contribute to hypertension in Africans [31–33]. Although Africans did not con-
sume more salt than Whites or Indians in a south-African study, they consumed more than 6
grams of salt per day, which is more than recommended by the WHO [34].
In this study, patients presented with advanced stages of heart failure, notably patients with
peripartum cardiomyopathy and rheumatic heart disease. In patients with peripartum cardio-
myopathy, severe heart failure and increased left ventricular end-diastolic diameter is associ-
ated with non-improvement of left ventricular function [35], and in patients with rheumatic
heart disease, it is too late for cardiac surgery in case of severe heart failure [17].
Fig 2. Medication taken before and prescribed after echocardiography in adults (A) and in children (B).
https://doi.org/10.1371/journal.pone.0208931.g002
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We observed only 32 (4%) cases of heart failure with preserved ejection fraction (HFpEF),
defined as heart failure with EF�50% and a conclusively measurable diastolic relaxation
impairment of grade 2 or 3 (i.e. elevated left ventricular filling pressure), following recent rec-
ommendations [9]. Studies from the USA and Europe indicate that up to 50% of patients with
heart failure have preserved ejection fraction [36], and two studies from sub-Saharan Africa
and one study including Latin American, middle-eastern, and North African regions reported
proportions of 53%-65% of HFpEF in their study populations [37–39]. In most studies includ-
ing those from Africa, the definition of HFpEF was based on clinical signs and symptoms of
heart failure and preserved left ventricular EF, and diastolic function was not reported. If we
would use a similar definition of HFpEF, we would count 405 (50%) cases with HFpEF, and if
the same echocardiographic criteria would be used as in an older American prospective study,
27% of our patients would have had isolated diastolic dysfunction and HFpEF, compared to
44% in that study [40].
In accordance to the high prevalence of not treated hypertension, the majority of our
patients were not treated for heart failure upon presentation–but after echocardiography,
patients were not only prescribed additional drugs, but unnecessary drugs were stopped, or
doses of established drugs adapted. Moreover, indication for oral anticoagulation and surgery
was made. Most prescribed drugs after performed echocardiography were ACE-Inhibitors,
diuretics, beta-blockers, and spironolactone. All of these drugs have an impact on morbidity
and mortality: ACE-inhibitors, beta-blockers and spironolactone reduce death and hospitaliza-
tion by about one third each, the latter in patients with severe heart failure only [41]. Before,
information on proportions of treated patients with heart failure was lacking for African
regions. All studies reporting on medication described drugs given at admission or at dis-
charge from a hospital, or the time of prescription was not defined [5].
Following echocardiography, 9% of the adult patients had an indication for oral anticoagu-
lation. However, to measure international normalized ratio (INR) was not possible in our set-
ting. Direct anticoagulants such as Rivaroxaban are available, but they are not affordable by
most of the patients. Thus, we could not anticoagulate patients with atrial fibrillation. Data
about the use of anticoagulants in sub-Saharan Africa except from south-Africa are scarce
[42]. A survey among cardiologists in Cameroon showed that only one third of patients with
an indication for anticoagulation because of atrial fibrillation received anticoagulation [43].
One study done in 6 tertiary hospitals in Nigeria found suboptimal usage of heparin or warfa-
rin to be common, with reduced awareness of direct anticoagulants among residents and con-
sultants [44].
One third of the children had an indication for cardiac surgery. While the outcome of con-
genital heart diseases such as Tetralogy of Fallot is poor without an intervention (only one
fourth reach the age of 10 years)[45], it is excellent after surgical repair [46], and the outcome
after mitral valve replacement in children is good, especially for older children [47]. However,
given the ratio of one cardiac center per 33.3 to 50.5 million people and only 1.6 open heart
operations per million people per year in sub-Saharan Africa [48], patients face a challenge to
get cardiac surgery, also because of unaffordably high costs.
The proportion of people living with HIV was 5% in our study population, which corre-
sponds to the national HIV prevalence of 5%[49]. One third of the children had underweight,
which is more than the prevalence of underweight in children 0 to 59 months (13.4% (95% CI
12.7–14.1) in the mainland of Tanzania [50]. Underweight in children with heart disease is
common, and depends on multiple factors such as severity of cardiac disease, increased energy
requirements, decreased nutritional intake, malabsorbtion, and poor utilisation of absorbed
nutrition [51].
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This study has several limitations: First, we could not follow-up all patients—thus we can-
not comment on long-term outcomes and survival rates or adherence to the prescribed medi-
cation. Meanwhile, (V.M) was trained in echocardiography, and clinical and
echocardiographic follow-up is done. Future trials performed at our site would allow to build a
cardiology center offering systematic follow-up and anticoagulation. Second, the diagnosis of
coronary heart disease was based on history, clinical examination, electrocardiogram, and
echocardiographic findings. In this rural setting, we could neither perform coronary angiogra-
phy nor myocardial scintigraphy nor stress-echocardiography. Thus, coronary heart disease
remained a suspected diagnosis. Third, we did not screen for cardiovascular risk factors other
than hypertension and overweight. One cross-sectional study including 9134 people living in
Ifakara showed that 5% had diabetes and 30% had hypertension. A total of 17% of men and 2%
of women did smoke, and 15% of men and 6% of women consumed alcohol. Only 8% led sed-
entary lives [52]. Forth, we could not perform myocardial biopsies, and histological determina-
tion of the origin of cardiomyopathies was not possible. Finally, existing echocardiographic
normograms for chamber size have not been validated for the African population.
This study has several strengths: The sample size is relatively large, compared to other stud-
ies; all patients referred for echocardiography were included prospectively, and patients were
examined regardless of their wealth status or availability of health insurance. Selection bias
could be minimized, as echocardiography is available only at our site for two large rural dis-
tricts of Tanzania, and virtually all patients referred for echocardiography from these districts
were included. We were able to present detailed echocardiographic measurements and inter-
pretations according to the latest recommendations, and medications were prescribed and sur-
gery recommended following current international guidelines.
In conclusion, hypertension is extremely common and mostly not controlled in rural Tan-
zania. The leading cause for heart disease in this setting is hypertension. Most patients pre-
sented with advanced stages of heart diseases, and the majority was not treated for heart failure
before echocardiography. There is an urgent need for community education to improve
awareness and to prevent hypertension, for trained staff, and for infrastructure to manage
hypertension and heart failure in rural Africa.
Supporting information
S1 Table. Detailed echocardiographic findings of all patients. LVEDD: left ventricular end-
diastolic diameter; IVSd: intraventricular septum in diastole; PWd: posterior wall in diastole;
LV: left ventricle; RWT: relative wall thickness; LVOT: left ventricular outflow tract; LA: right
atrium; LAVI: left atrial volume index; RA: right atrium; EF: ejection fraction; TAPSE: tricus-
pid annular plane systolic excursion; FAC: fractional area change; MV: mitral valve; DT: decel-
eration time; TR: tricuspid regurgitation; Pvein: pulmonary vein. N/A, not applicable. The
numbers (n = )/(n = ) indicate of how many adults and children, data were available. � Canti-
notti et al 2014 [14].
(DOCX)
S2 Table. Echocardiographic findings in adults (n = 815) with rheumatic heart disease and
peripartum cardiomyopathy. LVEDD: left ventricular end-diastolic diameter; IVSd: intra-
ventricular septum in diastole; PWd: posterior wall in diastole; LV: left ventricle; RWT: relative
wall thickness; LVOT: left ventricular outflow tract; LA: right atrium; LAVI: left atrial volume
index; RA: right atrium; EF: ejection fraction; TAPSE: tricuspid annular plane systolic excur-
sion; FAC: fractional area change; MV: mitral valve; DT: deceleration time; TR: tricuspid
regurgitation; Pvein: pulmonary vein. The numbers (n = )/(n = ) indicate for how many adults
Heart diseases in rural Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0208931 December 26, 2018 12 / 16
and children, data were available.
(DOCX)
S3 Table. Dataset adults.
(XLSX)
S4 Table. Dataset, children.
(XLSX)
Author Contributions
Conceptualization: Said Kilindimo, Winfrid Gingo, Christoph Hatz, Maja Weisser, Martin
Rohacek.
Data curation: Maja Weisser, Martin Rohacek.
Formal analysis: Dominick M. Raphael, Laurine Roos, Martin Rohacek.
Funding acquisition: Martin Rohacek.
Investigation: Victor Myovela, Elisante Mchomvu, Jabir Namamba, Martin Rohacek.
Methodology: Maja Weisser, Martin Rohacek.
Project administration: Martin Rohacek.
Resources: Winfrid Gingo.
Supervision: Martin Rohacek.
Visualization: Laurine Roos.
Writing – original draft: Dominick M. Raphael, Laurine Roos, Martin Rohacek.
Writing – review & editing: Victor Myovela, Elisante Mchomvu, Jabir Namamba, Said Kilin-
dimo, Christoph Hatz, Daniel H. Paris, Maja Weisser, Richard Kobza.
References
1. DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for
333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–
2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390
(10100):1260–344. https://doi.org/10.1016/S0140-6736(17)32130-X PMID: 28919118; PubMed Cen-
tral PMCID: PMCPMC5605707.
2. WHO. Global Health Estimates 2015: Death by Cause, Age, Sex, by Country and by Region, 2000–
2015. Geneva, World Health Organization. 2016.
3. Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Global mortality variations in patients
with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective
cohort study. Lancet Glob Health. 2017; 5(7):e665–e72. https://doi.org/10.1016/S2214-109X(17)
30196-1 PMID: 28476564.
4. Callender T, Woodward M, Roth G, Farzadfar F, Lemarie JC, Gicquel S, et al. Heart failure care in low-
and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2014; 11(8):
e1001699. https://doi.org/10.1371/journal.pmed.1001699 PMID: 25117081; PubMed Central PMCID:
PMCPMC4130667.
5. Agbor VN, Essouma M, Ntusi NAB, Nyaga UF, Bigna JJ, Noubiap JJ. Heart failure in sub-Saharan
Africa: A contemporaneous systematic review and meta-analysis. Int J Cardiol. 2018; 257:207–15.
https://doi.org/10.1016/j.ijcard.2017.12.048 PMID: 29506693.
6. Kwan GF, Bukhman AK, Miller AC, Ngoga G, Mucumbitsi J, Bavuma C, et al. A simplified echocardio-
graphic strategy for heart failure diagnosis and management within an integrated noncommunicable
disease clinic at district hospital level for sub-Saharan Africa. JACC Heart Fail. 2013; 1(3):230–6.
https://doi.org/10.1016/j.jchf.2013.03.006 PMID: 24621875.
Heart diseases in rural Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0208931 December 26, 2018 13 / 16
7. Tantchou Tchoumi JC, Ambassa JC, Kingue S, Giamberti A, Cirri S, Frigiola A, et al. Occurrence, aetiol-
ogy and challenges in the management of congestive heart failure in sub-Saharan Africa: experience of
the Cardiac Centre in Shisong, Cameroon. Pan Afr Med J. 2011; 8:11. PMID: 22121420; PubMed Cen-
tral PMCID: PMCPMC3201578.
8. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for car-
diac chamber quantification by echocardiography in adults: an update from the American Society of
Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc
Imaging. 2015; 16(3):233–70. https://doi.org/10.1093/ehjci/jev014 PMID: 25712077.
9. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommenda-
tions for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the
American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur
Heart J Cardiovasc Imaging. 2016; 17(12):1321–60. https://doi.org/10.1093/ehjci/jew082 PMID:
27422899.
10. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations
for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocar-
diography. J Am Soc Echocardiogr. 2003; 16(7):777–802. https://doi.org/10.1016/S0894-7317(03)
00335-3 PMID: 12835667.
11. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic
assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocar-
diogr. 2009; 22(1):1–23; quiz 101–2. https://doi.org/10.1016/j.echo.2008.11.029 PMID: 19130998.
12. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for
the echocardiographic assessment of the right heart in adults: a report from the American Society of
Echocardiography endorsed by the European Association of Echocardiography, a registered branch of
the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echo-
cardiogr. 2010; 23(7):685–713; quiz 86–8. https://doi.org/10.1016/j.echo.2010.05.010 PMID:
20620859.
13. Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age-specific reference intervals for indexed left ven-
tricular mass in children. J Am Soc Echocardiogr. 2009; 22(6):709–14. https://doi.org/10.1016/j.echo.
2009.03.003 PMID: 19423289.
14. Cantinotti M, Scalese M, Murzi B, Assanta N, Spadoni I, De Lucia V, et al. Echocardiographic nomo-
grams for chamber diameters and areas in Caucasian children. J Am Soc Echocardiogr. 2014; 27
(12):1279–92 e2. https://doi.org/10.1016/j.echo.2014.08.005 PMID: 25240494.
15. Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, et al. Recommendations for
quantification methods during the performance of a pediatric echocardiogram: a report from the Pediat-
ric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital
Heart Disease Council. J Am Soc Echocardiogr. 2010; 23(5):465–95; quiz 576–7. https://doi.org/10.
1016/j.echo.2010.03.019 PMID: 20451803.
16. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr., Drazner MH, et al. 2013 ACCF/AHA guideline
for the management of heart failure: a report of the American College of Cardiology Foundation/Ameri-
can Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 62(16):e147–239.
https://doi.org/10.1016/j.jacc.2013.05.019 PMID: 23747642.
17. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC
guideline for the management of patients with valvular heart disease: executive summary: a report of
the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J
Am Coll Cardiol. 2014; 63(22):2438–88. https://doi.org/10.1016/j.jacc.2014.02.537 PMID: 24603192.
18. Minette MS, Sahn DJ. Ventricular septal defects. Circulation. 2006; 114(20):2190–7. https://doi.org/10.
1161/CIRCULATIONAHA.106.618124 PMID: 17101870.
19. Villafane J, Feinstein JA, Jenkins KJ, Vincent RN, Walsh EP, Dubin AM, et al. Hot topics in tetralogy of
Fallot. J Am Coll Cardiol. 2013; 62(23):2155–66. https://doi.org/10.1016/j.jacc.2013.07.100 PMID:
24076489.
20. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr., et al. 2014 AHA/ACC/HRS
guideline for the management of patients with atrial fibrillation: a report of the American College of Car-
diology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
J Am Coll Cardiol. 2014; 64(21):e1–76. https://doi.org/10.1016/j.jacc.2014.03.022 PMID: 24685669.
21. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007; 370(9587):591–603. https://doi.
org/10.1016/S0140-6736(07)61299-9 PMID: 17707755.
22. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am J
Public Health. 1988; 78(6):676–9. PMID: 3259405; PubMed Central PMCID: PMCPMC1350281.
23. Remenyi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al. World Heart Federation criteria for
echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline. Nat Rev
Heart diseases in rural Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0208931 December 26, 2018 14 / 16
Cardiol. 2012; 9(5):297–309. https://doi.org/10.1038/nrcardio.2012.7 PMID: 22371105; PubMed Cen-
tral PMCID: PMCPMC5523449.
24. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of spe-
cific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994; 96(3):200–9. PMID:
8154507.
25. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowl-
edge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position
statement from the Heart Failure Association of the European Society of Cardiology Working Group on
peripartum cardiomyopathy. Eur J Heart Fail. 2010; 12(8):767–78. https://doi.org/10.1093/eurjhf/
hfq120 PMID: 20675664.
26. Grimaldi A, Mocumbi AO, Freers J, Lachaud M, Mirabel M, Ferreira B, et al. Tropical Endomyocardial
Fibrosis: Natural History, Challenges, and Perspectives. Circulation. 2016; 133(24):2503–15. https://
doi.org/10.1161/CIRCULATIONAHA.115.021178 PMID: 27297343.
27. Onen CL. Epidemiology of ischaemic heart disease in sub-Saharan Africa. Cardiovasc J Afr. 2013; 24
(2):34–42. https://doi.org/10.5830/CVJA-2012-071 PMID: 23612951; PubMed Central PMCID:
PMCPMC3734874.
28. Price AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, Musicha C, Tafatatha T, et al. Prevalence of
obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, pop-
ulation-based study in rural and urban Malawi. Lancet Diabetes Endocrinol. 2018; 6(3):208–22. https://
doi.org/10.1016/S2213-8587(17)30432-1 PMID: 29371076; PubMed Central PMCID:
PMCPMC5835666.
29. Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed
hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension. 2015; 65
(2):291–8. https://doi.org/10.1161/HYPERTENSIONAHA.114.04394 PMID: 25385758.
30. Antignac M, Diop IB, Macquart de Terline D, Kramoh KE, Balde DM, Dzudie A, et al. Socioeconomic
Status and Hypertension Control in Sub-Saharan Africa: The Multination EIGHT Study (Evaluation of
Hypertension in Sub-Saharan Africa). Hypertension. 2018; 71(4):577–84. https://doi.org/10.1161/
HYPERTENSIONAHA.117.10512 PMID: 29378852.
31. Garfinkle MA. Salt and essential hypertension: pathophysiology and implications for treatment. J Am
Soc Hypertens. 2017; 11(6):385–91. https://doi.org/10.1016/j.jash.2017.04.006 PMID: 28479261.
32. Yako YY, Balti EV, Matsha TE, Dzudie A, Kruger D, Sobngwi E, et al. Genetic factors contributing to
hypertension in African-based populations: A systematic review and meta-analysis. J Clin Hypertens
(Greenwich). 2018; 20(3):485–95. https://doi.org/10.1111/jch.13225 PMID: 29520984.
33. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005; 112
(23):3562–8. https://doi.org/10.1161/CIRCULATIONAHA.105.539569 PMID: 16330697.
34. Swanepoel B, Schutte AE, Cockeran M, Steyn K, Wentzel-Viljoen E. Sodium and potassium intake in
South Africa: an evaluation of 24-hour urine collections in a white, black, and Indian population. J Am
Soc Hypertens. 2016; 10(11):829–37. https://doi.org/10.1016/j.jash.2016.08.007 PMID: 27720143.
35. Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, et al. Phenotyping and outcome
on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic
Res Cardiol. 2013; 108(4):366. https://doi.org/10.1007/s00395-013-0366-9 PMID: 23812247; PubMed
Central PMCID: PMCPMC3709080.
36. Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat
Rev Cardiol. 2017; 14(10):591–602. https://doi.org/10.1038/nrcardio.2017.65 PMID: 28492288.
37. Abebe TB, Gebreyohannes EA, Tefera YG, Abegaz TM. Patients with HFpEF and HFrEF have different
clinical characteristics but similar prognosis: a retrospective cohort study. BMC Cardiovasc Disord.
2016; 16(1):232. https://doi.org/10.1186/s12872-016-0418-9 PMID: 27871223; PubMed Central
PMCID: PMCPMC5117494.
38. Bonsu KO, Owusu IK, Buabeng KO, Reidpath DD, Kadirvelu A. Clinical characteristics and prognosis of
patients admitted for heart failure: A 5-year retrospective study of African patients. Int J Cardiol. 2017;
238:128–35. https://doi.org/10.1016/j.ijcard.2017.03.014 PMID: 28318656.
39. Magana-Serrano JA, Almahmeed W, Gomez E, Al-Shamiri M, Adgar D, Sosner P, et al. Prevalence of
heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African
Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic
Function: an epidemiological regional study). Am J Cardiol. 2011; 108(9):1289–96. https://doi.org/10.
1016/j.amjcard.2011.06.044 PMID: 22000627.
40. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, et al. Systolic and diastolic
heart failure in the community. JAMA. 2006; 296(18):2209–16. https://doi.org/10.1001/jama.296.18.
2209 PMID: 17090767.
Heart diseases in rural Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0208931 December 26, 2018 15 / 16
41. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for
the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and
treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed
with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37
(27):2129–200. https://doi.org/10.1093/eurheartj/ehw128 PMID: 27206819.
42. Mazurek M, Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, et al. Regional Differences
in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry.
Thromb Haemost. 2017; 117(12):2376–88. https://doi.org/10.1160/TH17-08-0555 PMID: 29212125.
43. Ntep-Gweth M, Zimmermann M, Meiltz A, Kingue S, Ndobo P, Urban P, et al. Atrial fibrillation in Africa:
clinical characteristics, prognosis, and adherence to guidelines in Cameroon. Europace. 2010; 12
(4):482–7. https://doi.org/10.1093/europace/euq006 PMID: 20179174.
44. Anakwue R, Nwagha T, Ukpabi OJ, Obeka N, Onwubuya E, Onwuchekwa U, et al. Clinicians-related
determinants of anticoagulation therapy and prophylaxis in Nigeria. Ann Afr Med. 2017; 16(4):164–9.
https://doi.org/10.4103/aam.aam_35_17 PMID: 29063899; PubMed Central PMCID:
PMCPMC5676405.
45. Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME, Kirklin JW. Life expectancy without surgery in
tetralogy of Fallot. Am J Cardiol. 1978; 42(3):458–66. PMID: 685856.
46. Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anoma-
lies: a population-based study. Lancet. 2010; 375(9715):649–56. https://doi.org/10.1016/S0140-6736
(09)61922-X PMID: 20092884.
47. Henaine R, Roubertie F, Vergnat M, Ninet J. Valve replacement in children: a challenge for a whole life.
Arch Cardiovasc Dis. 2012; 105(10):517–28. https://doi.org/10.1016/j.acvd.2012.02.013 PMID:
23062483.
48. Yankah C, Fynn-Thompson F, Antunes M, Edwin F, Yuko-Jowi C, Mendis S, et al. Cardiac surgery
capacity in sub-saharan Africa: quo vadis? Thorac Cardiovasc Surg. 2014; 62(5):393–401. https://doi.
org/10.1055/s-0034-1383723 PMID: 24955755.
49. Ministry of Health, United Republic of Tanzania. Tanzania HIV Impact Survey 2016–2017. http://
wwwnbsgotz/nbs/takwimu/this2016-17/Tanzania_SummarySheet_Englishpdf. 2017.
50. Ministry of Health and Welfare, United Republic of Tanzania. Tanzania National Nutrition Survey 2014
https://wwwuniceforg/tanzania/Tanzania_National_Nutrition_Survey_2014_Final_Report_
18012015pdf. 2014.
51. Argent AC, Balachandran R, Vaidyanathan B, Khan A, Kumar RK. Management of undernutrition and
failure to thrive in children with congenital heart disease in low- and middle-income countries. Cardiol
Young. 2017; 27(S6):S22–S30. https://doi.org/10.1017/S104795111700258X PMID: 29198259.
52. Ramaiya A, Geubbels E. HIV and NCD: The burden of chronic disease in Rural Tanzania. Spotlight.
2014;https://drive.google.com/file/d/0B7y5ETfTjl4xREwyQUg0SkgzR0k/edit(19).
Heart diseases in rural Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0208931 December 26, 2018 16 / 16
